Indeed, cathepsin K deficiency has been linked to bone disorders such as pycnodysostosis and osteopetrosis [3,4], while the excessive activity of this enzyme may lead to osteoporosis [5], making it a likely target for rational drug design [6-8]. This evidence concerns the gene CTSK and osteoporosis.